Evidence map›Paper›PMID 41932965›Full record

ArticleScientific reports2026

Leaky recombinant expression reveals design constraints of bicistronic synthetic operons in Escherichia coli.

Stephan Gutmann, Christopher Tauer, Martin Wagenknecht, Gerald Striedner, Reingard Grabherr, Monika Cserjan-Puschmann

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Stephan GutmannChristian Doppler Laboratory for production of next-level biopharmaceuticals in E. coli, Department of Biotechnology and Food Science, BOKU University, 1190, Vienna, Austria.ORCID http://orcid.org/0009-0000-4674-5196
Christopher TauerChristian Doppler Laboratory for production of next-level biopharmaceuticals in E. coli, Department of Biotechnology and Food Science, BOKU University, 1190, Vienna, Austria.
Martin WagenknechtBiopharma Austria, Development Operations Vienna, Boehringer Ingelheim Regional Center Vienna GmbH & Co KG AT, Vienna, Austria.
Gerald StriednerChristian Doppler Laboratory for production of next-level biopharmaceuticals in E. coli, Department of Biotechnology and Food Science, BOKU University, 1190, Vienna, Austria.ORCID http://orcid.org/0000-0001-8366-5195
Reingard GrabherrChristian Doppler Laboratory for production of next-level biopharmaceuticals in E. coli, Department of Biotechnology and Food Science, BOKU University, 1190, Vienna, Austria.ORCID http://orcid.org/0000-0002-4501-927X
Monika Cserjan-PuschmannChristian Doppler Laboratory for production of next-level biopharmaceuticals in E. coli, Department of Biotechnology and Food Science, BOKU University, 1190, Vienna, Austria. monika.cserjan@boku.ac.at.ORCID http://orcid.org/0000-0002-9811-9709

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The simultaneous expression of multiple recombinant proteins in Escherichia coli is commonly achieved by synthetic operons containing one promoter, multiple ribosomal binding sites, and multiple recombinant genes. In these operons, the expression of the recombinant proteins is regulated, whereby operator/repressor combinations are often used for induction. Different approaches can be employed for co-expression of two or more recombinant proteins. Within this work, we created synthetic bicistronic systems with a single induction system. At the same time, the use of bicistronic systems can lead to increased complexity and potential regulatory issues in transcription and translation. In BL21(DE3), which is a common E. coli expression strain, leaky expression is associated with the basal expression of the T7 RNA polymerase (T7 RNAP). In addition, our research indicates that leaky expressions can also occur independently of the T7 RNAP and should be taken into consideration when designing synthetic bicistronic operons. By designing and testing multiple variants of one bicistronic system in two different E. coli strains, we identified potential promoter sequences causing leaky expression. We demonstrate that the design of a bicistronic expression system is critical for both the leaky and the induced expression of recombinant proteins.

Indexed as

Escherichia coliOperonRecombinant ProteinsDNA-Directed RNA PolymerasesGene Expression Regulation, BacterialPromoter Regions, GeneticViral Proteinsbacteriophage T7 RNA polymeraseDNA-Directed RNA PolymerasesRecombinant ProteinsViral Proteins

Identifiers

PMID41932965
PMCPMC13194763

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.